Developing vaccines to combat infectious diseases and bioterrorism
Advanced Development of Vaccine Candidates for Biodefense and Emerging Infectious Diseases
['FUNDING_OTHER'] · IMMUNARTES LLC · NIH-11161136
This study is working on developing new vaccines to help protect people from serious infections, especially during outbreaks or potential bioterrorism events, and it’s testing these vaccines in animals to make sure they are safe and effective.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | IMMUNARTES LLC (nih funded) |
| Locations | 1 site (Willowbrook, UNITED STATES) |
| Trial ID | NIH-11161136 on ClinicalTrials.gov |
What this research studies
This research focuses on creating and testing vaccine candidates that can be used in response to outbreaks of infectious diseases, including those that may arise from bioterrorism. The approach involves formulating and manufacturing vaccine components, conducting stability tests, and evaluating their effectiveness and safety through studies in animal models. If successful, these vaccines could provide critical protection against serious health threats posed by emerging infectious diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk of exposure to infectious diseases, particularly in outbreak situations.
Not a fit: Patients who are not at risk of infectious diseases or who have existing immunity to the targeted pathogens may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to effective vaccines that protect patients from serious infectious diseases and bioterrorism threats.
How similar studies have performed: Previous research has shown success in developing vaccines for infectious diseases, indicating a promising potential for this approach.
Where this research is happening
Willowbrook, UNITED STATES
- IMMUNARTES LLC — Willowbrook, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: THAMMAVONGSA, VILASACK — IMMUNARTES LLC
- Study coordinator: THAMMAVONGSA, VILASACK
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Communicable Diseases, Disease Outbreaks, Emerging Communicable Diseases, Emerging Infectious Diseases